"If you build a better mousetrap, you will catch better mice."
George Gobel
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7459151 | Phosphate-binding polymers for oral administration Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia. ... | 12/02/2008 |
| 7261880 | Methods of treating Syndrome X with aliphatic polyamines The invention relates to a method for treating Syndrome X, or inhibiting the onset of symptoms of Syndrome X in a patient, and includes administering a therapeutically effective amount of a salt of at least one alkylated and cross-linked polymer, or a copolymer ther... | 08/28/2007 |
| 7220406 | Method for promoting bone formation Amine polymers, particularly aliphatic amine polymers, are useful in the treatment and prevention of bone disease and in methods for promoting bone formation. Sevelemer, polyallylamine crosslinked with epichlorohydrin, which is sold under the tradename RenagelĀ®, is... | 05/22/2007 |
| 7153497 | Controlled dissolution of active ingredients A dosage form comprising a resin/resinate combination is described. Said dosage form allows optimization of the release rate profile of active ingredients. ... | 12/26/2006 |
| 7101960 | Process for removing bile salts from a patient and alkylated compositions therefor The invention relates to a method for reducing serum cholesterol in a patient in need thereof and alkylated and crosslinked poly(allylamine) polymers useful in the method. The alkylated and crosslinked poly(allylamine) polymers are crosslinked with epichlorohydrin a... | 09/05/2006 |
| 7087223 | Preventives and/or remedies for hyperphosphatemia Provided in a phosphate ion adsorbent containing a weakly basic anion exchange resin as an active ingredient which aims at providing preventives and/or remedies for hyperphosphatemia having a high selectivity for the adsorption of phosphate ion and showing an effect... | 08/08/2006 |
| 7067116 | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 Physiologically acceptable films, including edible films, are disclosed. The films include a water soluble film-forming polymer, such as pullulan, and a taste masked pharmaceutically active agent, such as dextromethorphan. The taste masking agent is preferably a sul... | 06/27/2006 |
| 7048917 | Fat-binding polymers The present invention relates to a method for treating obesity, a method for reducing the absorption of dietary fat, and a method for treating hypertriglyceridemia in a patient and to particular polymers for use in the methods or in a manufacture of a medicament. Th... | 05/23/2006 |
| 7014846 | Phosphate-binding polymers for oral administration Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia. ... | 03/21/2006 |
| 6992061 | Purification method The invention relates to a method of removing endotoxin from preparation of alpha-1-acid glycoprotein (orosomucoid) by contact with a finely divided non-toxic resin such as fumed silica. The invention also relates to a purification process for alpha-1-acid glycoprot... | 01/31/2006 |
| 6899868 | Iodine/resin disinfectant and a procedure for the preparation thereof The present invention relates to iodine demand disinfectants. It relates in particular to a process for preparing a polyiodide-resin for use as an iodine demand disinfectant wherein a porous strong base anion exchange resin in a salt form, is contacted with a materi... | 05/31/2005 |
| 6858203 | Method of making phosphate-binding polymers for oral administration Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia. ... | 02/22/2005 |
| 6680050 | Iodine/resin disinfectant and a procedure for the preparation thereof The present invention relates to iodine demand disinfectants. It relates in particular to a process for preparing a polyiodide-resin for use as an iodine demand disinfectant wherein a porous strong base anion exchange resin in a salt form, is contacted wi... | 01/20/2004 |
| 6592861 | Iodinated resin held to a carrier The present invention relates to iodine demand disinfectants. It relates in particular to a process for preparing a polyiodide-resin for use as an iodine demand disinfectant wherein a porous strong base anion exchange resin in a salt form, is contacted wi... | 07/15/2003 |
| 6509013 | Method of making phosphate-binding polymers for oral administration Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.... | 01/21/2003 |
| 6391294 | In situ formation of polymeric material A pharmaceutically acceptable bio-adhesive coating, film or gel is formed in situ at a body surface by the reaction of (i) an anionic polymer or tripolyphosphate and (ii) a cationic polymer in the presence of water. The two components are supplied either ... | 05/21/2002 |
| 6387877 | Purification method The invention relates to a method of removing endotoxin from preparations of alpha-1-acid glycoprotein (orosomucoid) by contact with a finely divided non-toxic resin such as fumed silica. The invention also relates to a purification process for alpha-1-ac... | 05/14/2002 |
| 6241980 | Sample processing method using ion exchange resin The present invention relates to methods in which ion exchange resins are used to reduce the amount of substances which interfere with nucleic acid hybridization in samples. The methods also stabilize the samples. Kits containing the ion exchange resins r... | 06/05/2001 |
| 6132706 | Methods of medical treatment for excess phosphate using guanidino-containing polymers The invention provides a physiologically acceptable polymer comprising a backbone to which are attached guanidino groups, the polymer having a minimum molecular weight of 10,000. The invention also extends to foodstuffs and pharmaceutical compositions com... | 10/17/2000 |
| 6083495 | Method of making phosphate-binding polymers for oral administration Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.... | 07/04/2000 |
| 6071508 | Preparation of formulations for electrotransport drug delivery A method is provided for preparing drug formulations suitable for electrotransport drug delivery. The drug to be delivered, present in salt form, is contacted with an ion exchange material prior to incorporation into the reservoir (26) of an electrotransp... | 06/06/2000 |
| 5968499 | Polymeric compounds A polystyrene polymer crosslinked by 1.5% to 8% with divinylbenzene based on the total weight of the polymer and having a minimum weight average molecular weight of 10000 wherein 50 to 100% of the aromatic groups of the polystyrene are substituted by at l... | 10/19/1999 |
| 5919832 | Amine polymer sequestrant and method of cholesterol depletion An amine polymer includes first and second substituents bound to amines of the polymer. The first substituent includes a hydrophobic moiety. The second substituent includes a quaternary amine-containing moiety. A method for binding bile salts of bile acid... | 07/06/1999 |
| 5698190 | Polymeric compounds The invention provides a physiologically acceptable polymer comprising a backbone to which are attached guanidino groups, the polymer having a minimum molecular weight of 10,000. The invention also extends to foodstuffs and pharmaceutical compositions com... | 12/16/1997 |
| 5683709 | Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions A package containing an aqueous drug composition containing an insoluble resin comprising benzalkonium salt units in an amount sufficient to inhibit growth of microbes in said aqueous drug solution. Typically, the insoluble resin is a polymer having repea... | 11/04/1997 |
| 5667775 | Phosphate-binding polymers for oral administration Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.... | 09/16/1997 |
| 5643560 | Drug formulation with ion-exchangers The invention relates to the use of, and methods to obtain, ion exchanger complexes with psychotropic drugs for reducing toxic side effects and lethality when overdosing the drug. The invention includes methods and compositions for modifying the total amo... | 07/01/1997 |
| 5496545 | Phosphate-binding polymers for oral administration Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.... | 03/05/1996 |
| 5464612 | Solid preparation comprising ion exchanger and active agent (A) A clad powdery or granular preparation of a medicinally active ingredient and (B) a powdery or granular ion exchanger such as a cation exchange resin are blended to prepare a solid preparation. The active ingredient includes ଲ-lactam antibiotics... | 11/07/1995 |
| 5460807 | Antiproliferative oligomers The oligomers of the present invention are polyureas or polyamides having a number average molecular weight of | 10/24/1995 |
| 5401498 | Pharmaceuticals comprising polyhydroxymethylene derivatives, process for their preparation and use The invention relates to a pharmaceutical containing an effective amount of a polyhydroxymethylene containing grafted ethoxylated alcohols and/or ethoxylated carboxylic acids. The pharmaceutical is used for the treatment of dyslipoproteinemias.... | 03/28/1995 |
| 5194246 | Anticalculus oral compositions containing combinations of polymers A method and composition for controlling calculus formation in the mouth is reported based upon a combination of a low and high molecular weight polymer. The first polymer is a synthetic anionic polymer having a molecular weight of at least 4000. The seco... | 03/16/1993 |
| 4898729 | Treatment of hypertension, compounds and compositions for antihypertension and diuresis Antihypertension action is achieved without diuresis by administration of a thiazide diuretic in an amount which while being sufficient to achieve antihypertension is insufficient to achieve diuresis. Such administration in a non-diuretic amount is effect... | 02/06/1990 |
| 4780322 | Method of producing slow-release pharmaceutical forms The invention relates to a novel method of producing slow-release pharmaceutical forms administered per os, by simultaneously employing two resins having anionic character, the proportions of said resins being variable. By varying the ratio of the amounts... | 10/25/1988 |
| 4777042 | Cholesterol level-lowering agents There is disclosed a cholesterol level-lowering agent which comprises as a main component a strongly basic anion exchange resin having imidazolium salts as functional groups, said resin being a copolymer of (A) a high molecular quaternary salt and (B) a p... | 10/11/1988 |
| 4774083 | Novel pharmaceutical tablets Novel tablets comprising (a) 80 to 98% by weight of a mixture of trimethoprim and/or an acid addition salt thereof and a sulfonamide and/or a salt thereof in a weight ratio of 1:20 to 20:1 and (b) a pharmaceutically acceptable synthetic ion exchange resin... | 09/27/1988 |
| 4762709 | Liquid prolonged release pharmaceutical formulations containing ionic constituents A formulation of a drug wherein the drug is present as a coated, drug-resin complex suspended in a liquid carrier which carrier also contains a second ionic component bearing the same charge as the coated complexed drug, the second ionic component being p... | 08/09/1988 |
| 4578268 | Diethylcarbamazine resinate and styrylpyridinium resinate-diethylcarbamazine resinate edible anthelmintic tablets for companion animals There are provided palatable anthelmintic resinate compositions for companion animals, containing anthelmintically effective amounts of a styrylpyridinium compound and/or an N,N-dialkylpiperazine carboxamide.... | 03/25/1986 |
| 4442086 | Diethylcarbamazine resinate and styrylpyridinium resinate-diethylcarbamazine resinate edible anthelmintic tablets for companion animals There are provided palatable anthelmintic resinate compositions for companion animals, containing anthelmintically effective amounts of a styrylpyridinium compound and/or an N,N-dialkylpiperazine carboxamide.... | 04/10/1984 |